Experiment name | Clinical attributes |
Alizadeh00_DLCL_0024_lc8n096 | Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), GC B like DLBCL (B lymphoma) |
Bhattacharjee01_AD-228t2-A152-4 * | Stage T2 (Lung cancer), Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*) |
Bhattacharjee01_AD-308t1-A241-8 | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Stage T1 (Lung cancer) |
Bhattacharjee01_SQ-3197-A323-5 | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Squamous cell lung cancer (Lung cancer) |
Boldrick02_Diversity_Dataset_S_aureus2_timecourse_24_0_hr | Lymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Stimulated immune cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), S. aureus stimulated immune cells (Stimulated PBMC) |
Boldrick02_Dose_Response_Dataset_Bp_LPS_1_0ug_ml_timecourse_12_0hr | Lymphocytes (Stimulated PBMC*), Monocytes (Stimulated PBMC*), Primary blood mononuclear cells (Stimulated PBMC*), Stimulated immune cells (Stimulated PBMC*), Hematologic samples (Stimulated PBMC*), Hematologic samples and cell lines (Stimulated PBMC*), Lipopolysaccharide (LPS) stimulated immune cells (Stimulated PBMC) |
Chen02_FNH_SF33 | Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Focal nodular hyperplasia (FNH) of the liver (Liver cancer) |
Chen02_HCC_HBV_HK1 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Invasive liver tumor (Liver cancer) |
Chen02_HCC_HBV_HK45 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*) |
Chen02_HCC_HBV_HK84 | Hepatocellular carcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer) |
Chen02_HCC_HBV_HK86 | Hepatocellular carcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer) |
Chen02_HCC_HBV_SF34_2 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*) |
Chen02_HCC_HK41 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer) |
Chen02_HCC_HK46 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), p53 positive hepatocellular carcinoma (Liver cancer) |
Chen02_Liver_HBV_HK1 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK19 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK27 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK30 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK33 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK36 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK38 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK47 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_HK49 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HBV_SF22 | Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer) |
Chen02_Liver_HK23 | Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer), Normal tissue (Liver cancer) |
Chen02_Liver_HK41 | Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer), Normal tissue (Liver cancer) |
Cuadras02_Tc_24h |
Garber01_185_96_Adeno | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Stage T1 (Lung cancer) |
Garber01_187_96_Adeno | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Stage T1 (Lung cancer) |
Garber01_68_96_Adeno | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Stage T1 (Lung cancer) |
Garber01_80_96_Adeno | Stage T2 (Lung cancer), Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*) |
Lessnick02_Run 2, Day 2 | Cell line (Fibroblast EWS-FLI*), Fibroblasts (Fibroblast EWS-FLI*), Cancer and cell line (Fibroblast EWS-FLI*), EWS/FLI expressing fibroblasts (Fibroblast EWS-FLI*), Skin fibroblasts (Fibroblast EWS-FLI*) |
Perou00_184A1_LATE | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*) |
Perou00_184Aa | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*) |
Perou00_184B5 | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*) |
Perou00_BC118A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC123A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC124B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC213A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC214A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC2_LN2 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC38_LN38 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC402B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC708A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_BC709A_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Perou00_HMEC_C | Breast cancer cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Human mammary epithelial cells - HMECs (Breast cancer), Human mammary epithelial cells (HMECs) or normal breast tissue (Breast cancer) |
Perou00_Hs578T_NCI | Breast cancer cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Mesenchemal cell line (Breast cancer) |
Perou00_MCF7_NCI | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*) |
Perou00_MOLT4 | Cell line (Breast cancer), Cancer and cell line (Breast cancer*) |
Perou00_SK_BR_3 | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*) |
Perou00_SW872 | Cell line (Breast cancer), Cancer and cell line (Breast cancer*), Mesenchemal cell line (Breast cancer) |
Ross00_MDA_MB_231_CL5005_BREAST | Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Ross00_NCI_H23_CL1001_NSCLC | Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*) |
Ross00_SR_CL7019_LEUKEMIA | Fast doubling (20-40) cell lines (NCI60), Cell line (NCI60*), Cancer and cell line (NCI60*), Leukemia cell line (NCI60), Hematologic samples and cell lines (NCI60), Hematologic cancer and cell line (NCI60) |
Ross01_BJ_hTERT_PD210_Fibroblasts_UTSW | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Ross01_BT474_Stanford |
Ross01_HB2 | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Ross01_HCC_1937 | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Ross01_Hs578T_ATCC | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Ross01_MCF_10A | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Sorlie01_BC104A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC106B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC108A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC119A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer) |
Sorlie01_BC120A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC121B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer) |
Sorlie01_BC125A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC14 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC2 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC201B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC205B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC20_FA | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Fibroadenoma (Breast cancer) |
Sorlie01_BC214B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer) |
Sorlie01_BC303B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC307B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC308B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC31_0 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC40 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC402B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 3 (Breast cancer) |
Sorlie01_BC404B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC405A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC406A_2ndTUMOR | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Sorlie01_BC44 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Grade 3 (Breast cancer) |
Sorlie01_BC45 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Sorlie01_BC48_0 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Grade 3 (Breast cancer) |
Sorlie01_BC4_LN4 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC503B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC6 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer) |
Sorlie01_BC605B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC606B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer) |
Sorlie01_BC608B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer) |
Sorlie01_BC610A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC702B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC704B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC706A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC713A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC807A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 3 (Breast cancer) |
Sorlie01_BC_HBC2 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC_HBC3 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC_HBC4_T1 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC_HBC5 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC_HBC6 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Sorlie01_Normal_Breast2 | Breast tissue, cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Human mammary epithelial cells (HMECs) or normal breast tissue (Breast cancer), Normal breast tissue (Breast cancer), Normal female hormonal tissue (Breast cancer), Normal female hormonal tissue and cells (Breast cancer), Normal tissue (Breast cancer) |
Sorlie01_Normal_Breast3 | Breast tissue, cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Human mammary epithelial cells (HMECs) or normal breast tissue (Breast cancer), Normal breast tissue (Breast cancer), Normal female hormonal tissue (Breast cancer), Normal female hormonal tissue and cells (Breast cancer), Normal tissue (Breast cancer) |
Whitfield02_0_2hr_Hela_Double_Thymidine | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |
Whitfield02_14_hr_Hela_Double_Thymidine_exp2 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |
Whitfield02_16_hr_Hela_Double_Thymidine_exp2 | Cell line (HeLa cell cycle*), Epithelial cell line (HeLa cell cycle*), HeLa cell line (HeLa cell cycle*), Cancer and cell line (HeLa cell cycle*) |